Gérard Degiovanni

755 total citations
10 papers, 385 citations indexed

About

Gérard Degiovanni is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Gérard Degiovanni has authored 10 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Gérard Degiovanni's work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Gérard Degiovanni is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Gérard Degiovanni collaborates with scholars based in Belgium, Switzerland and France. Gérard Degiovanni's co-authors include Thierry Boon, Annie Ooms, Sandra Morel, Benoı̂t J. Van den Eynde, Nathalie Vigneron, Jacques Chapiro, Pierre van der Bruggen, Vincent Stroobant, Thierry Lahaye and Philippe Hainaut and has published in prestigious journals such as Science, European Journal of Immunology and Cellular Immunology.

In The Last Decade

Gérard Degiovanni

9 papers receiving 377 citations

Peers

Gérard Degiovanni

IMMUN

MB

ONCOL

GENET

RNMI

D Landais France

Andrew Trimby United Kingdom

Nicole Lévy Switzerland

J W Chamberlain Canada

Gaëlle Bouvier France

Melissa Swope Willis United States

Anita Jekő Netherlands

Cole T. Thomson United States

R Linsk United States

T I Munitz United States

D Landais France

Gérard Degiovanni

208 ×0.8

IMMUN

162 ×0.7

MB

104 ×0.9

ONCOL

39 ×1.0

GENET

86 ×2.7

RNMI

Citations per year, relative to Gérard Degiovanni Gérard Degiovanni (= 1×) peers D Landais

Countries citing papers authored by Gérard Degiovanni

Since Specialization

Citations

This map shows the geographic impact of Gérard Degiovanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérard Degiovanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérard Degiovanni more than expected).

Fields of papers citing papers by Gérard Degiovanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérard Degiovanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérard Degiovanni. The network helps show where Gérard Degiovanni may publish in the future.

Co-authorship network of co-authors of Gérard Degiovanni

This figure shows the co-authorship network connecting the top 25 collaborators of Gérard Degiovanni. A scholar is included among the top collaborators of Gérard Degiovanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérard Degiovanni. Gérard Degiovanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Vigneron, Nathalie, Vincent Stroobant, Jacques Chapiro, et al.. (2004). An Antigenic Peptide Produced by Peptide Splicing in the Proteasome. Science. 304(5670). 587–590. 262 indexed citations

2.

Ooms, Annie, et al.. (2002). CD40 triggering increases the efficiency of dendritic cells for antitumoral immunization.. PubMed. 2. 2–2. 12 indexed citations

3.

Vigneron, Nathalie, Annie Ooms, Sandra Morel, Gérard Degiovanni, & Benoı̂t J. Van den Eynde. (2002). Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma.. PubMed. 2. 9–9. 18 indexed citations

4.

Geenen, Vincent, Eric Vandersmissen, Henri Martens, Gérard Degiovanni, & P Franchimont. (1993). Evidence for the association between human thymic MHC class I molecules and a dominant neurohypophysial thymic peptide. Open Repository and Bibliography (University of Liège). 1 indexed citations

5.

Geenen, Vincent, Henri Martens, Françoise Robert, et al.. (1991). Thymic cryptocrine signaling and the immune recognition of self neuroendocrine functions. Open Repository and Bibliography (University of Liège). 4. 9 indexed citations

6.

Degiovanni, Gérard, Philippe Hainaut, Thierry Lahaye, P. Weynants, & Thierry Boon. (1990). Antigens recognized on a melanoma cell line by autologous cytolytic T lymphocytes are also expressed on freshly collected tumor cells. European Journal of Immunology. 20(8). 1865–1868. 19 indexed citations

7.

Degiovanni, Gérard, Thierry Lahaye, Michel Hérin, Philippe Hainaut, & Thierry Boon. (1988). Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones. European Journal of Immunology. 18(5). 671–676. 54 indexed citations

8.

Degiovanni, Gérard & Nicole Schaaf‐Lafontaine. (1985). Direct in vitro inactivation of murine alloreactive cytotoxic-T-lymphocyte precursors by syngeneic nonspecific cytotoxic-T-cell populations. Cellular Immunology. 90(2). 474–484.

9.

Schaaf‐Lafontaine, Nicole, Jacques Boniver, Kris Huygen, & Gérard Degiovanni. (1984). Suppression of CTL responses in vitro by large granular T cells. Immunology Letters. 8(4). 201–206. 4 indexed citations

10.

Degiovanni, Gérard, Jean‐Charles Cerottini, & K. T. Brunner. (1980). Generation of cytolytic T lymphocytes in vitro. O XI. Accessory cell requirement in secondary responses to particulate alloantigen. European Journal of Immunology. 10(1). 40–45. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact